Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization\'s (WHO) Traditional Medicine Strategy 2014-2023 outlines a framework for action through the regulation,

67194067MU033L0

Integrating Artificial Intelligence (AI) into the health system has the potential to enhance efficiency, accessibility, and overall quality of medical services worldwide. In response to global advancements, Thailand proactively developed the National AI Strategy and Action Plan 2022–2027, which emphasises AI adoption in health as a national prior

Thailand has promoted the use of herbal medicine for many years, but the value of herbal medicine in public health facilities does not meet the established target. The survey of health practitioners towards herbal medicine and the policy in promotion of the use of herbal medicine in health practitioners gives us information reinforcing and resistan

There have been an increasing number of people undergoing cataract surgery in the past five years, especially with those under the Unicersal Coverage Scheme (UC). Improtant factors contributing to this have included an increase in the number of opthalmologists and an increase in the population of Thai provinces. For facotrs influencing the type of

This suggestion report aims to present how to manage and utilize the existing researches to policy and how to enhance the research capacity of the EMS agencies201-344-2553

The objective of this study is to determine the economic evaluation of absorbent products for urinary and fecal incontinence among disabled and elderly people in Thailand by taking the monthly average expense of adult diapers, incontinence pads of approximately 2,000 Baht per person into consideration.While a majority of disabled people and depende

The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted

Patients with Down’s syndrome have developmental delay and abnormalities in their biological system. Most of the patients cannot take care of themselves. They must have long term treatment which is quite expensive. Currently there is no curative therapy for Down’s syndrome. Screening and prenatal diagnosis to detect abnormalities of Down’s sy

1. BackgroundSince 2011 the Ministry of Public Health (MOPH) and the National Health Security Office (NHSO) has collaborated in health promotion and disease prevention program, which aims to provide a high quality of health promotion and disease prevention services for all Thai people. Although the NHSO has indicators for health promotion and disea